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The origin of tissue-resident macrophages, crucial for homeostasis and immunity, has 
remained controversial until recently. Originally described as part of the mononuclear 
phagocyte system, macrophages were long thought to derive solely from adult blood 
circulating monocytes. However, accumulating evidence now shows that certain mac-
rophage populations are in fact independent from monocyte and even from adult bone 
marrow hematopoiesis. These tissue-resident macrophages derive from sequential 
seeding of tissues by two precursors during embryonic development. Primitive macro-
phages generated in the yolk sac (YS) from early erythro-myeloid progenitors (EMPs), 
independently of the transcription factor c-Myb and bypassing monocytic intermediates, 
first give rise to microglia. Later, fetal monocytes, generated from c-Myb+ EMPs that 
initially seed the fetal liver (FL), then give rise to the majority of other adult macrophages. 
Thus, hematopoietic stem cell-independent embryonic precursors transiently present in 
the YS and the FL give rise to long-lasting self-renewing macrophage populations.
Keywords: macrophages, monocytes, fetal liver, yolk sac, C-Myb, erythro-myeloid progenitors, hematopoiesis, 
hematopoietic stem cells
introduction
Ilya (Elie) Metchnikoff first described the mechanism of phagocytosis and the cells responsible for 
this process over a century ago. These professional phagocytic cells were named “macrophages” 
(from the Greek derivation macro = large and phage = devouring, “large devouring cells”). These 
were separate from “microphages,” which included polymorphonuclear phagocytes (1). Determining 
the role of macrophages in pathogenic infections was one of the fundamental observations leading to 
the concept of cellular immunity (2). Through this seminal work, Metchnikoff anticipated the central 
role of macrophages in tissue inflammation and homeostasis. We recommend an elegant historical 
review for more details about Metchnikoff ’s work by Yona and Gordon in this issue (3).
Since then, the definition of the phagocyte system has been continuously refined, and our under-
standing of the wide-ranging functions of macrophages has been substantially expanded. It is now 
clear that, in addition to their classical function in the activation and resolution of tissue inflamma-
tion, macrophages also play roles in tissue-specific functions, tissue remodeling during angiogenesis 
and organogenesis, and wound healing, to name a few (4). Macrophages are exquisitely adapted to 
their local environment, acquiring organ-specific functionalities during developmental stages and 
the steady state (4). Macrophages are able to support multiple tissue functions, integrating cues from 
both the outside environment and their microenvironment to act as rheostatic cells of tissue function. 
Thus, tissue-resident macrophages represent an attractive target for modern medicine to treat a wide 
spectrum of diseases in which they have been implicated, including atherosclerosis, autoimmune 
diseases, neurodegenerative and metabolic disorders, and tumor growth (5–8). Understanding the 
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origin and developmental pathways of macrophages will help to 
design novel intervention strategies targeting these cells in tissue-
specific sites.
A number of observations now indicate that certain 
macrophage populations derive from embryonic precursors 
sequentially seeding tissues during development (9–13). Two 
macrophage progenitors, yolk sac (YS) macrophages and fetal 
monocytes, have been described in the embryo, but their exact 
nature and origin were not fully understood until recently (14, 
15). Here, we discuss recent developments in our understanding 
of the origin of adult tissue-resident macrophages, exploring the 
sequence of progenitors generated during embryonic and adult 
hematopoiesis. We focus on the relative contributions of YS 
macrophages and fetal or adult monocytes, including a discus-
sion of our own recent data exploring the heterogeneity of fetal 
monocyte developmental pathways.
early Concepts
Macrophages form part of the mononuclear phagocyte system 
(MPS), which also includes circulating monocytes and dendritic 
cells (16). Until recently, our vision of macrophage origin and 
homeostasis was largely based on seminal studies that used 
in vivo radioisotope labeling and radiation chimera experiments. 
These studies led to the early dogma that resident macrophages 
were constantly replenished from circulating bone marrow (BM)-
derived monocytes as a continuum of differentiation (17–19).
In agreement with that concept, studying the ontogeny of the 
MPS revealed that monocytes and macrophages derived from 
macrophage and dendritic cell progenitors (MDPs) present in 
the BM, which are phenotypically defined as lineage-c-kit+CX
3CR1+Flt3+CD115+ (20). MDPs further differentiate through a 
newly described common monocyte precursor (cMoP), pheno-
typically defined as lineage−c-kit+CX3CR1+Flt3−CD115+ (21), 
that gives rise to the two main subsets of circulating monocytes 
distinguished by the expression of Ly6C (22).
Specific tissue macrophages, such as dermal, gut, and heart 
macrophages, seemed to follow the model of Van Furth, that 
macrophages are derived from monocytes (23–25). However, this 
model did not fit in all cases and evidence also emerged indicating 
that macrophages were long-lived cells, able to self-renew locally. 
Hashimoto was the first to speculate that Langerhans cells (LCs) 
represented a self-perpetuating “intraepithelial phagocytic sys-
tem” (26). Performing a human skin transplantation assay onto 
nude mice, Krueger et  al. described the remarkable longevity 
of LCs, which were able to persist in the grafts for more than 
2 months (27). Their ability to self-renew through proliferation 
was later described using DNA densitometry (28). Similar con-
clusions were drawn soon after regarding alveolar macrophages 
(29). The dominant concept of “the monocytic origin” of tissue 
macrophages was also challenged through experiments in ani-
mals with prolonged monocytopenia following strontium-89 
monocyte depletion, in which liver Kupffer cells were shown to 
maintain cell numbers by increasing local proliferation (30, 31).
More recently, the use of long-term parabiotic mice and sub-
sequent fate-mapping models have challenged the MPS paradigm 
and revealed that, unlike all other hematopoietic cells, which 
rely on hematopoietic stem cell (HSC)-derived BM progeni-
tors, certain macrophage populations possess the unique ability 
to self-renew locally independently of circulating precursors 
(32–36). Initial studies describing the presence of macrophages 
in embryonic tissues suggested that tissue macrophages derived 
from embryonic progenitors. In rodents, macrophage-like cells 
first described in the brain rudiment and in the developing skin 
(37, 38) were named “fetal macrophages” and found to exhibit 
a high capacity for proliferation (39). These observations sug-
gested that adult macrophages derive from fetal macrophages 
established during early development. However, whether these 
fetal macrophages were maintained until adulthood or were 
replaced postnatally was not addressed until recently. In addition, 
the exact nature and the origin of fetal macrophage progenitors 
remained unclear.
embryonic Hematopoiesis
Mammalian embryos produce several transient waves of hemat-
opoietic cells before the establishment of HSCs in the BM during 
late gestation (40, 41). The multiple embryonic waves are differ-
entially regulated in time and space and exhibit distinct lineage 
potentials. Importantly, they contribute to hematopoietic popula-
tions that persist until adulthood. These waves include primitive 
hematopoiesis in the YS, and definitive hematopoiesis, which 
comprises a transient definitive stage, generating multi-lineage 
erythro-myeloid progenitors (EMPs) and lympho-myeloid pro-
genitors (LMPs), and a definitive stage characterized by the 
production of HSCs in the aorta-gonad-mesonephros (AGM). 
These transient progenitors establish themselves transiently in 
the fetal liver (FL) during the mid to late stages of hematopoiesis. 
The sequential waves of hematopoiesis can overlap in time and 
space (Figure 1) and remain difficult to separate clearly, even with 
the most recent fate-mapping tools available.
Primitive Hematopoiesis
In mice, the first hematopoietic progenitors appear in the 
extra-embryonic YS blood islands at around embryonic age 7.25 
(E7.25), where primitive hematopoiesis is initiated, producing 
mainly nucleated erythrocytes. This observation linked the 
myeloid progenitors observed in the YS at E7 with the emergence 
of YS macrophages after E9.0 [Figure 2; Ref. (42–45)]. Primitive 
hematopoiesis was also shown to produce megakaryocyte pro-
genitors (46). The denomination “primitive” was given to reflect 
the production of embryonic erythroblasts, like those observed in 
lower species such as fish, amphibians, and birds, and remaining 
nucleated throughout their life span (47–49). This denomination 
was extended to macrophages in the YS due to their concomitant 
development prior to FL hematopoiesis. Interestingly, no clear 
evidence of monocytic intermediates was reported at this stage, 
although the seminal study of Cline and Moore did mention the 
existence of local intermediate cells between progenitors and 
functional macrophages (43). Studies by Naito and Takahashi 
et  al. clarified the emergence of primitive macrophages in the 
YS blood islands in the mouse and rat, observing an absence 
of endogenous peroxidase activity as a surrogate marker for an 
absence of monocytic intermediates, such as those found in the 
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BM (50–52), suggesting a unique developmental pathway for YS 
macrophages (53, 54).
Transient Definitive Hematopoiesis
The quest to elucidate the origins of embryonic HSCs led to 
the discovery of earlier lineage-restricted HSC-independent 
progenitors seeding the FL at E10.5. These progenitors arise 
concurrently with the transition of primitive to definitive 
erythropoiesis and were thus considered to form a transient 
stage of definitive hematopoiesis (45, 47, 55). Transient defini-
tive hematopoiesis consists of progenitors sequentially acquir-
ing myeloid, then lymphoid potential, without exhibiting the 
long-term reconstitution potential of HSCs. Seminal work from 
Palis and colleagues on embryonic erythropoiesis in the YS 
described the parallel emergence of multiple myeloid lineage 
FiGURe 1 | Fetal hematopoiesis. Primitive, transient definitive, and definitive waves of fetal hematopoiesis sequentially generate progenitors able to seed the fetal 
liver. Primitive hematopoiesis starts at E7.0 in the blood islands of the extra-embryonic yolk sac (YS) and generates erythro-myeloid progenitors (EMPs). Early EMPs 
initially express CD41 and later, CSF-1R, a signature of myeloid/macrophage commitment. Concomitant to the establishment of the blood circulation at E8.5, the YS 
hemogenic endothelium (HE) generates late EMPs expressing C-Myb. At approximately E9.0, the intra-embryonic mesoderm generates additional HE and emerging 
progenitors with lymphoid potentials (LMPs) without long-term reconstitution (LTR) capacity. These C-Myb+ EMPs and LMPs constitute the so-called transient 
definitive wave. Finally, hematopoietic stem cells (HSCs) with LTR activity emerge from the main HE situated in the aorta-gonad-mesonephros (AGM) regions and in 
the placenta.
potential progenitors from E8.25 in the YS (45). Palis et al. first 
observed the emergence of definitive progenitors for mast cells 
and a bipotential granulocyte/macrophage progenitor. These 
progenitors then migrated to the FL through the bloodstream 
after E8.5, once circulation was established (44, 56). From this 
pattern of development, the authors concluded that definitive 
hematopoietic progenitors arise in the YS, migrate through the 
bloodstream, and seed the FL to rapidly initiate the first phase 
of intra-embryonic hematopoiesis. Similarly, primitive and 
definitive erythropoiesis, associated with myelopoiesis, was also 
shown to emerge prior to HSC in the zebrafish embryo (57). 
Bertrand et  al. showed that definitive hematopoiesis initiates 
in the posterior blood island with only transient proliferative 
potential. Because these HSC-independent definitive progeni-
tors were observed to produce definitive erythroid and myeloid 
FiGURe 2 | Primitive hematopoiesis and yolk sac macrophage ontogeny. Early EMPs emerge in the YS around E7.5 before establishment of the blood 
circulation. They express CD41 and CSF-1R and are independent of the transcription factor C-Myb. Upon establishment of the blood circulation around E8.5, EMPs 
differentiate into primitive macrophages as well as primitive erythrocytes and granulocytes. Primitive macrophages seed all fetal tissues, in particular the head where 
they will give rise to future brain microglia that are able to continuously self-renew throughout adulthood. EMPs seeding the fetal liver briefly expand to generate a 
local macrophage population, likely important for sustaining enucleation of primitive erythrocytes passing through the sinusoid prior to the establishment of definitive 
hematopoiesis and the generation of fetal monocyte-derived macrophages in the fetal liver.
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cell types, but not to colonize the zebrafish thymus (implying 
that they are devoid of lymphoid potential), this population was 
termed EMPs (57). Interestingly, EMPs can also emerge from 
the hemogenic endothelium (HE) located in the placenta and 
umbilical cord (58) and colonize the FL from E9.5 (55) to par-
ticipate in definitive hematopoiesis. Further studies advanced 
the field significantly by identifying CD41 as an early marker 
(pre-CD45) for defining hematopoietic progenitors, including 
EMPs, emerging from the YS (59, 60). Altogether, these impor-
tant studies provided phenotypic and functional analyses of the 
first hematopoietic progenitors and demonstrated that defini-
tive hematopoiesis proceeds through two distinct waves during 
embryonic development (Figure 3).
In parallel, several groups have also identified other multipo-
tential progenitors with lymphoid- or myelo-lymphoid-restricted 
potential in the YS and the developing para-aortic splanchno-
pleura (P-Sp) prior to HSCs (61, 62). Lacaud et al. also described 
AA4.1 (CD93)+ multipotential progenitors present in the E14.5 
FL with T cell, B cell, and macrophage potential (63), although 
the precise origin of these progenitors was not addressed. At the 
same time, the team of Jacobssen identified Flt3+ lympho-myeloid 
progenitors (LMPs) devoid of erythrocyte and megakaryocyte 
capacity (64). Later, cells with myelo-erythroid and lymphoid 
lineage potential, such as B-1 cells present in the adult spleen, 
were associated with E9.5 YS progenitors expressing AA4.1 and 
CD19 (65). A year later, the same team also identified T cell 
potential within the E9.5 YS progenitors (66). Using a Rag-1-Cre 
fate-mapping model, Boiers et  al. confirmed that these LMPs 
emerged at approximately E9.5 in the YS, seeding the FL by E11.5 
to give rise to T and B cells, as well as granulocytes and monocytes 
in the E14.5 FL, prior to HSCs (67). Finally, lympho-myeloid 
progenitors isolated from the dorsal aorta at E9.0 were shown 
to acquire long-term reconstitution capacity after a few days of 
in  vitro culture with stromal cells, and were called immature 
HSCs (68). Without preculture, these multipotential progenitors 
can only engraft natural killer (NK)-deficient Rag2γc−/− mice. 
FiGURe 3 | Fetal monopoiesis and macrophage ontogeny. At E8.5 as the blood circulation is established, the YS HE, possibly in conjunction with other 
hemogenic sites, generates EMPs expressing CD41 and c-Myb. These late EMPs seed the fetal liver around E9.5 where they expand rapidly to give rise to CSF-1R+ 
myeloid progenitors that are able to generate fetal monocytes through cMoP intermediates at E12.5. Fetal monocytes then spread via the blood circulation to all 
tissues, with the exception of the brain, which is isolated by the establishment of the blood–brain barrier at approximately E13.5. In the tissues, fetal monocytes 
begin to differentiate into macrophages, progressively outnumbering the previously established primitive macrophages. These fetal monocyte-derived macrophages 
maintain the capacity to self-renew throughout adulthood in certain tissues, such as the liver or the lung, where they will not be replaced by adult BM-derived 
monocytes.
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Whether these immature HSCs arise from LMPs or represent 
a distinct wave of progenitors remains to be clarified. However, 
these seminal studies provided strong evidence that lymphoid 
potential can emerge from the YS, prior to HSC-budding from 
the AGM (69).
Because the emergence of EMPs and LMPs overlaps in time 
and space, they could not be distinguished clearly until recently. 
Previous reports had suggested that lymphoid potential was 
restricted to the CD41-negative cell fraction (59, 65). However, 
CD41 is also expressed in a sub-fraction of FL HSCs, and so this 
phenotypical distinction spread some confusion (47). Finally, 
a recent report from the group of Palis clarified this point by 
showing that co-expression of c-kit, CD41, and CD16/32 defines 
EMPs and allows their separation from other progenitors with 
lymphoid potential, such as those giving rise to the B-1 cell (70). 
McGrath et  al. extended the notion of EMPs by showing their 
potential to generate neutrophils, megakaryocytes, macrophages, 
and erythrocytes. Finally, transplantation of EMPs in immune-
compromised adult mice can also provide transient adult red 
blood cell reconstitution (70).
To conclude, commitment to hematopoietic fates begins dur-
ing gastrulation in the YS, which represents the only site of primi-
tive erythropoiesis and also serves as the first source of transient 
definitive hematopoietic progenitors. HE develops from the YS 
to various intra-embryonic sites, and acquires myeloid and then 
lymphoid lineage potentials in overlapping waves, highlighting 
the complexity of the hematopoietic output. Whether some of 
these progenitors arise from independent sources or represent 
different maturation stages of a shared hematopoietic wave, cul-
minating with the generation of HSCs, needs to be further clari-
fied. However, it is tempting to speculate that the clear contrasts 
in differentiation/lineage potential do not reside in their intrinsic 
potential, but rather in the extrinsic signals provided by the local 
environment.
Definitive Hematopoiesis
The complex hierarchy of stem and progenitor cells in the BM 
is first established during embryonic development starting 
with the emergence of small numbers of HSCs from the AGM 
at E10.5 in murine embryos or at 5  weeks in human embryos 
FiGURe 4 | Transition between fetal and adult hematopoiesis. Hemogenic endothelial cells from extra and intra-embryonic hematopoietic tissues generate 
C-Myb-dependent multipotential progenitors, such as LMPs and pre-HSCs, between E9.0 and E10.5, culminating with the emergence of mature HSCs with 
long-term reconstitution-bearing potential. CD93 (AA4.1) expression is associated with the emergence of lymphoid potential, whereas Sca-1 is the hallmark of 
HSCs. These progenitors seed the fetal liver around E10/E11, expanding and giving rise to the various lineages of the hematopoietic system, including fetal 
monocytes. These late fetal monocytes continue to participate in the tissue-resident macrophage network until hematopoiesis switches completely from the fetal 
liver to the bone marrow. Once adult hematopoiesis begins to take place in the bone marrow generating monocytes, certain tissues, such as the dermis, heart 
peritoneum, and the gut, continue to recruit adult monocytes to generate resident macrophages and replace with time the embryonic-derived macrophages.
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(71, 72). After E9.5 in the mouse, with the determination of the 
intra-embryonic mesoderm toward a hematopoietic lineage, new 
waves of hematopoietic progenitors emerge within the HE of the 
embryo proper (Figure 4), first in the P-Sp region and the umbili-
cal and vitelline arterial regions of the embryo, then in the AGM 
region and the placenta (55, 73, 74). The hematopoietic activities 
of the P-Sp and AGM first generate immature HSCs and then 
mature HSCs, which are defined by their capacity to reconstitute 
adult conventional mice (long-term reconstitution; LTR). Both 
immature and mature HSCs seed the FL at approximately E10.5 
(68, 71, 75, 76) to establish definitive hematopoiesis (40, 77, 78). 
A maturation step seems necessary for immature HSCs to express 
their LTR activity in full, which is then maintained until adult-
hood (68). However, further investigations using a fate-mapping 
system would be necessary to confirm this model.
The FL becomes the major hematopoietic organ after E11.5, 
generating all hematopoietic lineages. Importantly, the FL 
itself does not produce progenitors de novo, but rather recruits 
progenitors derived from the YS and other hemogenic sites, to 
initiate definitive hematopoiesis (79) in parallel with the expan-
sion of the definitive HSC population before their migration to 
the spleen and BM (80).
The contribution of HSCs to FL hematopoiesis is complex 
to evaluate, partly because of the lack of specific fate-mapping 
models, and also the relatively limited knowledge regarding 
embryonic HSC maintenance and homeostasis in this environ-
ment. The capacity for long-term reconstitution, which defines 
functional HSCs, is present in the AGM by E10.5 (76). However, 
lineage-specific commitment may not occur in  vivo imme-
diately after reaching the FL environment. A number of other 
progenitors generated during transient definitive hematopoiesis, 
as discussed above, are already present and able to give rise to 
almost all cell lineages, which could prevent HSC consumption 
and differentiation (Figure 5). Evaluation of HSC contribution 
has long been based on the assumption that all hematopoietic 
cells in the FL were derived from HSCs as is the case in the BM 
(81). Many multipotential progenitors share the same phenotype 
with pre-HSC and HSCs, such as the expression of CD41 and 
AA4.1 (60), adding to this confusion. The combination of the 
marker Sca-1 and new markers such as those from the SLAM 
family (82) have greatly helped to clarify the characterization of 
HSCs, defined now as Lin−ckit+Sca-1+CD150+CD48−CD244−. 
However, no specific fate-mapping model exists to characterize 
embryonic HSC progeny with the exception of the Flt3-Cre 
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model (83), which was used until now with the assumption that 
embryonic and adult HSCs follow similar differentiation path-
ways. Our recent report suggests that the Flt3-Cre model can 
also be used to follow the progeny of LMPs (15). Furthermore, 
in the nascent BM, the long-term repopulation (LTR) capacity 
that characterizes functional HSCs is only observed at around 
E17.5 (84). Considering the time required to initiate full HSC 
differentiation, these data suggest that proper adult HSC-derived 
hematopoiesis does not take place in the BM until a few days 
after birth. Characterization of the functional specificities and 
regulatory pathways of HE that give rise to HSCs versus those 
that generate EMPs and other multipotential progenitors could 
aid the development of new fate-mapping models and improve 
our understanding of this process (85). Use of other fate-mapping 
models such as the Runx1-Mer-Cre-Mer (Runx1-iCre) (86), 
Tie2-Mer-Cre-Mer mice (14), and the c-kit-Mer-Cre-Mer mice 
(87) provided complementary results, although a careful analysis 
of the targeted cells in time and space is not yet fully available 
for the last two models. We present here our best interpretation 
of the data provided in these two recent studies that have used 
these models in light of the literature and our own results and 
experience using the Runx1-iCre model (Figure 6).
embryonic and Adult Precursors of Adult 
Tissue-Resident Macrophages
Yolk Sac Macrophages
Yolk sac macrophages first appear in the YS blood islands at E9 
(albeit in small numbers) with a unique pattern of differentiation 
that bypasses the monocytic intermediate stage seen in adult mac-
rophages (50, 52). YS-derived primitive macrophages spread into 
the embryo proper through the blood as soon as the circulatory 
system is fully established (from E8.5 to E10) (56), and migrate 
to various tissues, including the brain. Importantly, this occurs 
before the onset of fetal monocyte production by the FL, which 
starts around E11.5/E12.5 (92). These primitive macrophages 
retain the high proliferative potential observed in the YS as they 
FiGURe 5 | Timeline of fetal and adult hematopoiesis. The primitive hematopoiesis is initiated in the yolk sac independently of C-Myb activity, and generates 
early CSF-1R+ EMPs that give rise to YS macrophages without monocytic intermediates during a short time window and will establish the brain microglia. The 
transient definitive hematopoiesis and then the definitive hematopoiesis are both dependent on C-Myb activity and generate progenitors that differentiate in the fetal 
liver. The transient definitive wave, which include EMPs and then LMPs, give rise in particular to fetal monocytes that seed the tissues prior to birth to establish the 
self-renewing tissue-resident macrophage network. Although only HSCs, which result from the definitive hematopoiesis, seem to be maintained in the bone marrow 
in adults, the relative contribution of the transient definitive wave to the adult immune system remains unclear.
colonize various tissues (52, 93–95). Primitive macrophages may 
contribute to many fundamental processes during mid and late 
embryogenesis, such as clearance of dead cells or tissue matura-
tion. In this regard, the developmental process of interdigital 
cell death removal during the mouse footplate remodeling that 
occurs between E12.5 and E14.5 is of interest as the interdigit 
regions become heavily populated by macrophages and most of 
the dead cells were shown to be rapidly engulfed by macrophages 
(96). However, mouse models devoid of primitive macrophages 
such as the colony-stimulating factor 1 receptor (CSF-1R) KO 
(Florent Ginhoux, unpublished data,) and PU.1 KO (97) appears 
to exhibit a normal interdigit web tissue. Wood et al. observed 
that interdigit web tissue in PU.1 KO was only slightly retarded, 
suggesting that other cell type such as neighboring mesenchymal 
cells were compensating (97). In addition, we recently showed 
that depletion of primitive macrophages and hence of embryonic 
microglia, affected the progression of dopaminergic axons in the 
forebrain and the laminar positioning of subsets of neocortical 
interneurons, likely through phagocytic mechanisms (98).
Schulz et al. highlighted further differences between primitive 
and definitive hematopoiesis, showing that the latter relies on 
the transcription factor Myb, while YS-derived macrophages are 
Myb-independent, and are instead dependent on PU.1 (12). This 
again reinforces the view that YS-derived macrophages constitute 
an independent lineage, distinct from the progeny of definitive 
HSCs. Schulz et  al. exploited the differential dependence of 
primitive versus definitive hematopoiesis on the transcription 
factor c-Myb and reported that E16.5 tissue macrophage popula-
tions were not affected by the loss of c-Myb. Using a CSF-1R-iCre 
fate-mapping model of YS macrophages, they also reported the 
persistence of YS macrophages progeny in adult tissue-resident 
macrophage populations (lung, liver, and pancreas, as well as in 
the brain and skin), although the level of labeling was minimal 
(below 3–5%) and decreased with time. The authors concluded 
that tissue-resident macrophages were therefore derived from 
a c-Myb-independent lineage via YS macrophages (12), data 
supporting the initial report showing that microglia arise from 
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YS macrophages (9). Embryonic origin of macrophages was 
further supported by the work of Yona et al. and Hashimoto et al. 
showing that adult monocytes do not substantially contribute 
to tissue macrophages under steady-state conditions (13, 33). 
Furthermore, Yona et al. suggested the existence of a CX3CR1+ 
precursor for some of the monocyte-independent macrophages, 
FiGURe 6 | Fate-mapping systems. (A) The Runx-iCre fate-mapping model (86) used in our study targets the hemogenic transition (88), hence, labeling 
specifically progenitors in the process of budding out from the hemogenic endothelium. The Runx1 expression decreases in progenitors once they start to express 
Vav thus reducing the chances of tagging released progenitors from precedent waves (88). As a consequence, Runx-iCre tagging is restricted to a short time 
window in the lifespan of a given progenitor and allows a sharp definition of each hematopoietic wave. However, this model also restricts the tagging to only a small 
fraction of the targeted progenitor wave. (B) Tie2 is expressed in all endothelial cells that constitute the hemogenic endothelia even before the hemogenic transition 
(89). Thus, all endothelial cells and their progeny (non-hematopoietic and hematopoietic cells) will be labeled after tamoxifen injection using the Tie2-iCre model. As a 
consequence, an early tamoxifen injection (such as at E7.5) will result in the tagging of all hematopoietic cells emerging before the time of analysis. This will include 
progenitors from the primitive, the transient definitive, and the definitive waves if, for example, the analysis is done at E11.5. A late injection (such as at E10.5) will 
restrict the tagging to only the latest hematopoietic stem cells wave as they are just budding from HEs (90). Thus, this model might not be suitable to clearly 
separate the primitive from the transient definitive waves of hematopoiesis. However, this model could be important to study late HSC progeny as no other 
progenitors than HSCs emerge from HE after E10.5 (91). (C) C-kit is expressed by all hematopoietic progenitors and does not label endothelial cells that constitute 
the HEs (89). An early tamoxifen injection (such as at E7.5) will restrict the labeling to early progenitors making suitable the c-kit-iCre model to study the primitive 
hematopoiesis. However, the FL recruits progenitors of each hematopoietic wave from E8.5 until E11 (79). These progenitors still express c-kit and coexist after 
seeding the FL during the time necessary for their differentiation (47, 55). A later tamoxifen injection (such as at E9.5) might thus result in the cumulative labeling of 
undifferentiated primitive and definitive progenitors, including the transient wave of EMPs and LMPs. Thus, such model may not be suitable to resolve the complexity 
of the different embryonic hematopoietic waves characterized by short time windows of emergence and strong overlapping tendencies. Primitive hematopoietic 
progenitors are rapidly consumed and the engagement of EMPs and LMPs in FL hematopoiesis reduces the expression of c-kit on their surface. Thus, later 
tamoxifen injection (such as at E11.5) could restrict the labeling to newly derived HSCs expressing high level of c-kit without labeling precedent progenitor waves 
(87). Such model might be interesting to study the progeny of late HSCs although the risk of tagging the progeny of EMPs and LMPs or later committed progenitors 
derived from HSCs remains high and difficult to exclude. Further analysis would be necessary to clarify the potential of such model.
although the exact nature of this precursor was not elucidated. In 
fact, both YS macrophages and fetal monocytes express CX3CR1 
(9, 11, 15) and could therefore correspond to the unidentified 
precursors suggested by Yona et al. However, using a CSF-1R-
iCre fate-mapping model, also used by Schulz et al. (12), another 
study noted that the YS macrophage contribution in the brain, 
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the adult liver, and the heart was maintained although at a mini-
mal level that decreased with time (99). Interestingly, the level of 
labeling was always higher in microglia than that in the liver or 
the heart, suggesting that the level of YS macrophage contribu-
tion may differ between tissues and that YS macrophages may 
be differently replaced over time by later waves of progenitors, 
which follow tissue-distinct kinetics (discussed below). Our 
own report using the Runx1-iCre fate-mapping model (86) 
indicated that only microglia, specialized macrophages of the 
central nervous system, were derived solely from primitive 
macrophages while all other tissue macrophages derived from 
definitive hematopoiesis (9).
To understand whether YS macrophages might be the sole 
progenitors of every other adult macrophages, we asked what 
impact their in  utero depletion would have on the subsequent 
generation of fetal tissue macrophages. CSF-1R is expressed on 
YS macrophages and fetal monocytes, but only the development 
of the former is actively dependent on CSF-1R (9, 11). Thus, we 
attempted to deplete YS macrophages by transiently inhibiting 
the CSF-1R signaling pathway using a blocking anti-CSF-1R 
antibody, as recently described (98). Importantly, after complete 
depletion of primitive YS macrophages in E10.5 embryos and thus 
of most macrophages in treated embryos at E14.5, tissue mac-
rophages (including microglia) were able to repopulate to normal 
levels before birth. These data suggest that YS macrophages are 
dispensable for the generation of tissue-resident macrophages in 
the embryo, and that another CSF-1R-independent embryonic 
precursor can functionally replace YS macrophages during 
development (15, 98). Using a combination of both the CSF-1R-
iCre and the Runx1-iCre fate-mapping models, we noted that 
although YS macrophages infiltrate all tissues (including lung, 
liver, kidney, skin, gut, heart, pancreas, and stomach) until E13.5, 
a second wave of precursors, with a monocytic morphology and 
phenotype, supersedes them after E14.5 with the exception of 
the brain where YS macrophages are maintained until adulthood 
(15). A fuller understanding of this process may help to resolve 
some of the earlier discrepancies regarding the contribution of 
YS macrophages.
Fetal Monocytes
Fetal monocytes were described by Naito et  al. (92). Focusing 
their study on liver Kupffer cells (the resident macrophages of the 
liver) during embryonic development, they exploited the endog-
enous peroxidase activity of monocytes and pro-monocytes 
granules described earlier by van Furth et  al. (18, 92). Naito 
et al. observed the transient appearance of peroxidase activity, a 
signature for monocyte and pro-monocyte granule activity, dur-
ing the in vitro generation of macrophages from a preparation 
of FL-dissociated cells (92). In the YS and at early stages of FL 
development, no peroxidase activity was observed, suggesting 
that primitive macrophages first seed the FL. At a later stage, 
the peroxidase activity increased, suggesting the presence of 
monocytic intermediates. In vitro clonal expansion assays con-
firmed the existence of two types of colonies, those containing 
fetal monocytes and those devoid of them. This provided early 
evidence for the existence of two distinct developmental path-
ways leading to the generation of Kupffer cells, although at this 
stage, direct differentiation of fetal monocytes into macrophages 
in vivo had not been demonstrated (100).
To investigate the developmental event leading to the emer-
gence of tissue-specific macrophages, we initially focused on 
the LC, the specialized myeloid population of the epidermis. 
While YS macrophages seed the embryonic skin before E13.5, we 
discovered that the major fraction of adult LCs is in fact derived 
from fetal monocytes that are generated in the FL from E12.5 and 
are then recruited into fetal skin at E14.5 (11). These cells share 
a similar phenotype to their adult counterparts; however, they 
are generated independently of CSF-1R expression (9, 11). They 
possess high proliferative potential, and, in contrast to their adult 
counterparts, express few genes related to pathogen recognition 
and immune activation (15). Further studies should clarify 
whether such differences reflect monocyte immaturity imposed 
by a sterile fetal environment, or rather dedicated functional 
specializations that have yet to be unraveled. In utero adoptive 
transfers combined with fate-mapping studies unequivocally 
confirmed in situ differentiation of fetal monocytes into adult LCs 
(11). Fetal monocytes were then demonstrated to be the precur-
sor of adult macrophages in lung alveoli by intranasal injection 
(10, 101). Fetal monocytes were also shown to be involved in 
the generation of adult macrophages of the heart (99). In fact, 
fetal monocytes become the major leukocyte within the blood 
circulation after E13.5, spreading to all tissues. This occurred 
independently of the CCL2/CCR2 axis (15), suggesting an 
alternative mechanism of exit from the FL and/or recruitment 
by fetal tissues. Moreover, we were able to fate-map, from before 
birth to adulthood, the local differentiation of fetal monocytes 
into resident macrophages, by taking advantage of the specific 
expression of S100a4 in fetal monocytes compared to YS mac-
rophages (15). Only the brain remained free from fetal monocyte 
infiltration, possibly resulting from the isolation of the brain by 
the nascent blood–brain barrier as early as E13.5 (15, 102). Thus, 
these data now reveal that fetal monocytes are the major circulat-
ing embryonic precursor for all macrophages, with the exception 
of the brain. The absence of monocyte precursor contribution to 
the microglial pool could result from a lack of intrinsic potential 
or a lack of access to the developing brain due to the nascent 
blood–brain barrier. Interestingly, we observed a major influx of 
monocytes in the brain at E14.5 in our YS macrophage depletion 
model, and preliminary data using our fetal monocyte S100a4-
Cre/WT fate-mapping model combined with in utero depletion 
of YS macrophages suggest that fetal monocytes are capable of 
giving rise to microglia under certain conditions (Hoeffel & 
Ginhoux, personal communication). Whether this atypical fetal 
monocyte infiltration reflects a compensatory mechanism to 
fulfill an empty niche in the brain or results from a disruption of 
the blood–brain barrier remains to be investigated.
Adult Monocytes
BM-derived circulating monocytes were considered the only 
precursors for all tissue-resident macrophages since the seminal 
work of van Furth et  al. (17–18). Although this dogma was 
entirely revisited recently with the emergence of sophisticated 
fate-mapping tools as well as parabiotic models, the physi-
ological contribution of circulating adult monocytes to the adult 
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macrophage network remains valid at least in certain tissues. 
The continuous recruitment of circulating monocytes to the 
dermis has been shown to shape the adult dermal macrophage 
network (25). Although this study did not employ fate-mapping 
techniques, Tamoutounour’s data suggest the existence in the 
dermis of both a prenatal pool of macrophages and a second 
pool derived from adult blood monocytes. The authors argue 
that the dermis, in contrast to the epidermis, continues to recruit 
circulating monocytes in adulthood, most likely facilitated by 
its high level of vascularization. The macrophage network in the 
intestine follows a similar model. Data from Bain et al. suggest 
that embryonic macrophages do not persist in adulthood in the 
gut, and are replaced constantly by circulating adult monocytes 
(23), convincingly showing that adult monocytes are the source 
of intestine-resident macrophages. The role of commensal 
microbiota in this process is supported by the observation that 
the use of germ-free animals or treatment with broad-spectrum 
antibiotics results in a significant reduction in the recruitment 
of Ly6C+ monocytes to the colon (23). The macrophage network 
of the heart has also been shown to contain a component of YS 
macrophages and fetal monocyte-derived macrophages, both of 
which are maintained in adulthood (99). However, similar to the 
dermis and the gut, adult monocytes seem to replace embryonic 
macrophages progressively over time (24). The decreasing capac-
ity for self-renewal of embryonic macrophages with age observed 
by Molawi et  al. may explain the requirement for continuous 
recruitment of monocyte-derived macrophages to the heart in 
the absence of inflammation. It remains to be clarified whether 
this phenomenon occurs in other tissues as a result of aging. In 
agreement, proliferation of YS macrophages and fetal monocytes 
is very high during development (20–40% before E14.5) but 
decreases progressively to 10% few days after birth in most tis-
sues and decreases to almost undetectable levels in adults (15). 
Interestingly, macrophage turnover seems different from one 
tissue to another. Following BrdU incorporation at steady state, 
almost no proliferation was observed in adult gut macrophages 
(23), while 2–5% was measured in adult heart macrophages 
(24). Macrophage proliferation activity can also be mobilized 
upon inflammation. For example, peritoneal macrophages can 
increase their proliferation rate from 1 to 9% in response to 
parasite infection or in response to IL-4 stimulation (35), while 
enhanced local proliferation of macrophages in atherosclerotic 
lesions sustain disease progression (103). The characterization of 
local signals regulating macrophage proliferation as well as the 
presence of specialized tissue niches that sustain macrophage 
survival, proliferation, or even “stemness” will be fundamental to 
better understand their tissue homeostasis.
The macrophage network of the lymphoid system seems to 
follow a similar pattern than in the gut and dermis. Although 
the lymph nodes (LN) start to develop very early in the embryo 
(104), they become functionally active only within the first week 
after birth recruiting and organizing B and T cell areas when fol-
licles start to shape with connections to afferent lymphatics via 
the subcapsular sinus (105). Although macrophages are known 
to participate in lymphangiogenesis during development, notably 
by the production of VEGF (106, 107), the precise origin of the 
different LN macrophage populations remain poorly understood 
(108). The high level of foreign antigens passing through the LN 
during the lifespan, support the model of a constant replenish-
ment of the local macrophage pool by circulating adult mono-
cytes. However, the work of Jakubzick et al. suggests otherwise 
as tissue-patrolling monocytes at steady state seem to enter the 
LN without any sign of local differentiation to macrophages or 
dendritic cells (34). Further studies using fate-mapping systems 
should be addressed to clarify this point. Spleen macrophages are 
generated prenatally (13, 33). However, red pulp macrophages 
and marginal zone macrophages seem highly dependent, respec-
tively, on the transcription factor SPI-C (109) and on the nuclear 
receptor LXR (110), also expressed by circulating monocytes and 
suggest again that embryonic-derived macrophages are replaced 
over time by adult monocytes-derived macrophages. The use of 
the S100a4-Cre fate-mapping model in our hands supports these 
observations and similar conclusions were obtained for BM and 
peritoneal macrophages (15). Although tissue microenviron-
ment shapes certain macrophage functional specificities (111), 
through an ontogenic point of view, the composition of each 
tissue-resident macrophage pool evolves throughout life and the 
respective origins of each macrophage population may account 
for some of their key functions and cellular behaviors in a given 
tissue. Hence, a new challenge is to understand if an embryonic 
or adult origin matters for the function and the activation states 
of tissue-resident macrophages.
Origin and Development of YS 
Macrophages and Fetal Monocytes
Origin of YS Macrophages
Bertrand et  al., in line with the seminal work of Palis (45), 
described two sequential myeloid waves within the early YS 
(42). Using an in  vitro culture reporter system, Bertrand et  al. 
observed a first wave of monopotent progenitors that gave rise 
only to macrophages, followed by a second wave that gave rise 
to a mix of granulocytes, monocytes, and macrophages. More 
recently, Kierdorf et  al. revisited the work of Bertrand et  al. 
exploiting organotypic embryonic brain slices to demonstrate 
that microglial cells derived from YS EMPs (112). Kierdorf et al. 
also showed that these EMPs did not express the transcription 
factor c-Myb, associating them with the progenitors reported 
by Schulz et al. (12), although a direct link with the generation 
of microglia in vivo in adulthood was not conclusively demon-
strated. More recently, Perdiguero et  al. used the CSF-1R-iCre 
fate-mapping model to show that YS macrophages are derived 
from CSF-1R+ EMPs (14). Hence, these two studies suggest 
that YS macrophages, and thus microglia, would originate from 
c-Myb-independent CSF-1R+ EMPs. Furthermore, Perdiguero 
et al. demonstrated that CSF-1R+ EMPs were able to seed the FL 
by E10.5, suggesting that these progenitors could later populate 
other tissue niches and produce YS-like macrophage later during 
development in others tissues. Nevertheless, these data do not 
explain the low percentage of labeled adult macrophages observed 
by Schulz et al. using the CSF-1R-iCre fate-mapping model (12). 
Later observations by Epelman et al. (99), and more recently by 
our group using the same fate-mapping model (15), indicated 
that the ability of CSF-1R+ EMP to reach the FL could explain 
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the surprising maintenance of primitive macrophages until E16.5 
in c-Myb null embryos, where primitive macrophages generated 
in the YS as well as in the FL would be able to fulfill the empty 
niche left by the absence of c-Myb-dependent myeloid cells, that 
include fetal monocytes. However, this may not reflect the physi-
ological situation and may instead result from a compensatory 
mechanism to ensure the presence of macrophages in all tissues 
in the absence of c-Myb activity and fetal monocytes. Using the 
same CSF-1R-iCre fate-mapping model (15), we were able to 
follow the maintenance of microglia in the brain by self-renewal 
from E10.5 until adulthood, linking them with CSF-1R+ EMPs 
and confirming the previous observations of Perdiguero et  al. 
(14). However, for all other macrophage populations, the reduc-
tion of fate-mapping reporter labeling after E13.5 confirmed the 
progressive replacement of YS macrophages by another unlabeled 
precursor arising from a different hematopoietic wave.
We previously showed that Runx1+ YS progenitors that 
emerged at E7.5 give rise to YS macrophages and microglia (9, 11). 
Using both the Runx1-iCre and the CSF-1R-iCre fate-mapping 
models, we showed that these E7.5 Runx1+ YS progenitors were 
in fact the same CSF-1R+ EMPs described by Perdiguero et  al. 
and Kierdorf et  al., which contributed to the generation of YS 
macrophages and, to a lesser extent, those seeding the FL (14, 15, 
112). However, we also observed their disappearance from the FL 
after E11.5 indicative of a rapid local consumption/differentiation 
rather than long-term maintenance. Our results also suggest that 
these early CSF-1R+ EMPs are able to contribute to a short-term 
maintenance of macrophages in the FL (Figure  2), but do not 
contribute to other tissue macrophages as evidenced by their rapid 
disappearance from the blood circulation after E14.5 (15). This 
transient population in the FL may be due to a local immediate 
requirement for macrophages, at least during the onset of FL 
hematopoiesis, to perform efficient enucleation of primitive eryth-
rocytes passing through the FL sinusoids (100, 113). Combining 
historical evidences showing their direct lineage connection with 
the emergence of YS macrophages and recent findings showing 
their independence with c-Myb activity, we propose that CSF-1R+ 
EMPs should be designated as primitive EMPs.
Origin of Fetal Monocytes
Because adult monocytes are derived from HSCs in the BM, it 
would be reasonable to assume that embryonic HSCs might also 
give rise to fetal monocytes in the developing liver. In agreement 
with this hypothesis, we have identified a population in the FL 
similar to adult MDPs that have the potential to generate fetal 
cMoPs and monocytes following in vitro culture (15). Exploiting 
the Flt3-Cre tomato fate-mapping model (83), we then fol-
lowed the progeny of embryonic HSCs. However, the poor 
labeling observed between E14.5 and E17.5 in FL monocytes and 
macrophages contrasted with the strong labeling of FL MDPs, 
suggesting that HSCs had limited involvement in the generation 
of fetal monocytes (15). Nonetheless, the limited but significant 
labeling in fetal monocytes and macrophages at birth suggested 
an increasing derivation from fetal HSCs, assuming that fetal 
HSCs follow a similar Flt3-dependent differentiation pathway as 
adult HSCs. In parallel, gene array analysis highlighted a strong 
lymphoid signature within fetal MDPs (15), indicative of their 
derivation from the recently described YS-derived LMPs (67). 
Thus, LMPs may be important for the generation of a small but 
significant proportion of fetal monocytes prior to the expansion 
of mature HSCs (Figure  4). Further investigations using more 
specific fate-mapping models will be necessary to elucidate the 
exact contribution of LMPs as well as the hematopoietic transi-
tion between the FL and the BM.
Importantly, we observed that fetal monocytes were not 
tagged with the CSF-1R-Cre model that label early CSF-1R+ 
EMPs, suggesting that fetal monopoiesis is not dependent on 
CSF-1R+ EMPs, consistent with our previous data (9, 11) and 
with our YS macrophage depletion results (15, 98). Furthermore, 
the Runx1-iCre fate-mapping model allowed us to identify two 
waves of EMPs that arise sequentially before LMPs in the YS. 
These included an early wave, arising at E7.5 that differentiates 
locally into YS macrophages; and a later wave tagged at E8.5, that 
migrates and seeds the FL following the establishment of the blood 
circulation before E9.0. Early EMPs tagged at E7.5 were therefore 
related to those described previously by Kierdorf and Perdiguero 
(14, 112). The late EMPs tagged at E8.5, however, expressed 
c-Myb, expanded more efficiently in the FL, and differentiated 
in vivo into fetal cMoPs, constituting the major component of the 
fetal monocyte population as well as the fetal monocyte-derived 
macrophage population (Figure 3), which was able to maintain 
itself in all tissues tested (15).
The existence of two distinct EMP waves is in agreement 
with Bertrand et al. who reported an early wave of macrophage 
progenitors restricted to the YS, and a second wave that was able 
to reach the FL to participate in definitive hematopoiesis (42). 
The differential expression of c-Myb between early and late EMPs 
is in agreement with previous reports indicating that primitive 
hematopoiesis can occur in the absence of c-Myb, especially for 
the generation of monopotent macrophage progenitors (114), 
whereas EMPs from definitive hematopoiesis express and are 
dependent on c-Myb activity (45, 62, 115).
Notably, a previous study showed that c-Myb ablation strongly 
compromises definitive hematopoiesis (116). Palis et al. observed 
that c-Myb is expressed prior to and during the early develop-
ment of definitive erythrocyte progenitors (45). Thus, late EMPs 
and LMPs, as well as HSCs, express c-Myb (15, 45, 61, 62), 
suggesting that the entire fetal monopoiesis machinery is reliant 
on this transcription factor. In agreement, the CD11bhiF480lo 
population, which in our hands contains fetal monocytes, was 
completely absent in the c-Myb-deficient embryo (12, 116). As a 
consequence, the contribution of c-Myb-dependent progenitors 
to tissue-resident macrophage populations could not be evalu-
ated in c-Myb-deficient embryos, where c-Myb-independent YS 
macrophages maintain themselves as a compensatory mecha-
nism due to the absence of c-Myb-dependent fetal monocytes 
that normally outcompete them. Because c-Myb expression is 
upregulated during the successive steps of fetal monopoiesis 
(15), the switch in EMP localization between the YS and the 
FL may indeed be orchestrated by c-Myb. As a consequence, 
most tissue-resident macrophages derived from fetal monocytes 
would therefore rely on c-Myb activity. Altogether we propose 
that c-Myb+ EMPs giving rise to the first circulating monocytes 
should be designated as definitive EMPs.
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Conclusion
Recent reports have drastically changed the view of the develop-
ment of the MPS and shed light on the multiple layers that define 
fetal hematopoiesis. It is now evident that fetal monocytes form 
the major precursors of most adult tissue-resident macrophages, 
and further investigations are now necessary to clarify how 
they shape macrophage heterogeneity. Examining how tissues 
imprint specific fates in these circulating precursors will aid our 
understanding of the mechanisms that control the tissue-specific 
functions of macrophages in the steady state, and thus may 
uncover new therapeutic opportunities in diverse pathological 
settings such as metabolic diseases, fibrosis, and carcinogenesis.
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